This analysis only examines coverage policies for semaglutide, not other potential barriers such as co-pays and coinsurance
Understanding your genetic predispositions in appetite and incretin pathways can support a more informed conversation with your gastroenterologist or primary care provider about whether compounded GLP-1 therapy (semaglutide, tirzepatide, or microdose protocols) is appropriate for your gastroparesis status
Nat Rev Neurol 17:515521
You might be wondering, "Did I get a dud?" or "Is my body just resistant to this?"
Published trial endpoints show meaningful changes over months, with major body-weight endpoints measured at 24, 48, 68, 80, and 104 weeks
Rare but Serious Causes Including Malignancies In some cases, black stools can be a sign of a serious condition like cancer